A systematic review of interventions to improve adherence to endocrine therapy
- PMID: 30387003
- PMCID: PMC7093203
- DOI: 10.1007/s10549-018-5012-7
A systematic review of interventions to improve adherence to endocrine therapy
Abstract
Purpose: Adherence to endocrine therapy for hormone positive breast cancer is a significant problem, especially in minority populations. Further, endocrine therapy reduces recurrence and thus mortality. However, little data are available on interventions to improve adherence. The authors conducted a systematic review to examine the impact of interventions, strategies, or approaches aimed to improve endocrine therapy adherence among women with breast cancer. A secondary aim was to determine if interventions had any cultural modifications.
Methods: Two of the authors examined articles published between 2006 and 2017 from a wide variety of databases using Covidence systematic review platform.
Results: In total, 16 eligible studies met criteria for review including 4 randomized controlled trials, 4 retrospective studies, and 8 with various observational designs. Eligible studies used a broad range of definitions for adherence and measured adherence by self-report, medical records, claims data, and combinations of these. All used 80% medication possession ratio as a standard for adherence. Patient information/education was the most frequent intervention strategy but did not demonstrate a significant effect except in one study. Significant results were noted when education was combined with communication strategies.
Conclusions: Researchers need a standard definition for adherence and a reliable measure that is feasible to use in a variety of studies. While education may be a necessary component of an intervention, when used alone, it is not a sufficient approach to change behavior.
Keywords: Adherence; Breast cancer; Endocrine therapy; Interventions; Systematic review.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts.
Figures
References
-
- Early Breast Cancer Clinical Trialsists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. 2005;365(9472):1687–1717. - PubMed
-
- Fontein DBY, Nortier JWR, Liefers GJ, et al. High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial. EJSO. 2012;38(2):110–117. - PubMed
-
- Kesmodel SB, Goloubeva OG, Rosenblatt PY, et al. Patient-reported adherence to adjuvant aromatase inhibitor therapy using the Morisky Medication Adherence Scale: An evaluation of predictors. Am J Clin Oncol. 2018;41(5):508–512. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
